Sinovac Biotech Ltd (SVA) — Net Asset Quality Index
Sinovac Biotech Ltd (SVA) has a Net Asset Quality Index of 79.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $8.14 Billion minus total liabilities of $1.67 Billion yields net assets of $6.46 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read SVA total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sinovac Biotech Ltd Net Asset Quality Index Over Time (1998–2025)
This chart shows how Sinovac Biotech Ltd's Net Asset Quality Index has evolved across 27 annual periods from 1998 to 2025. As of June 2026, the index stands at 79.4%, representing net assets of $6.46 Billion against total assets of $8.14 Billion USD. For live market cap and overall valuation, see SVA stock market capitalisation.
Annual Net Asset Quality Index for Sinovac Biotech Ltd (1998–2025)
The table below presents the year-by-year Net Asset Quality Index for Sinovac Biotech Ltd from 1998 to 2025, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check SVA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.1% | $6.40 Billion | $8.64 Billion | $2.23 Billion | ▼ -9.3 pp |
| 2024 | 83.4% | $10.29 Billion | $12.34 Billion | $2.04 Billion | ▼ -4.6 pp |
| 2023 | 88.0% | $12.02 Billion | $13.66 Billion | $1.64 Billion | ▼ -2.0 pp |
| 2022 | 90.1% | $12.71 Billion | $14.11 Billion | $1.40 Billion | ▲ +7.2 pp |
| 2021 | 82.9% | $13.88 Billion | $16.75 Billion | $2.87 Billion | ▲ +23.9 pp |
| 2020 | 58.9% | $1.12 Billion | $1.90 Billion | $781.20 Million | ▼ -19.0 pp |
| 2019 | 77.9% | $352.19 Million | $452.30 Million | $100.10 Million | ▼ -1.1 pp |
| 2018 | 78.9% | $291.93 Million | $369.78 Million | $77.85 Million | ▲ +17.6 pp |
| 2017 | 61.3% | $129.67 Million | $211.35 Million | $81.69 Million | ▲ +0.0 pp |
| 2016 | 61.3% | $129.67 Million | $211.35 Million | $81.69 Million | ▼ -5.9 pp |
| 2015 | 67.3% | $136.50 Million | $202.93 Million | $66.42 Million | ▲ +7.9 pp |
| 2014 | 59.4% | $141.73 Million | $238.53 Million | $96.80 Million | ▼ -0.3 pp |
| 2013 | 59.7% | $143.64 Million | $240.69 Million | $97.05 Million | ▼ -2.3 pp |
| 2012 | 62.0% | $129.44 Million | $208.76 Million | $79.33 Million | ▼ -5.3 pp |
| 2011 | 67.3% | $145.30 Million | $215.91 Million | $70.61 Million | ▼ -1.6 pp |
| 2010 | 68.9% | $147.76 Million | $214.36 Million | $66.60 Million | ▲ +10.9 pp |
| 2009 | 58.1% | $84.47 Million | $145.48 Million | $61.01 Million | ▼ -11.2 pp |
| 2008 | 69.3% | $53.64 Million | $77.44 Million | $23.80 Million | ▲ +12.0 pp |
| 2007 | 57.3% | $32.90 Million | $57.45 Million | $24.55 Million | ▼ -0.3 pp |
| 2006 | 57.6% | $21.31 Million | $37.01 Million | $15.70 Million | ▼ -13.1 pp |
| 2005 | 70.6% | $16.51 Million | $23.37 Million | $6.86 Million | ▲ +1.2 pp |
| 2004 | 69.4% | $15.56 Million | $22.42 Million | $6.86 Million | ▼ -3.7 pp |
| 2003 | 73.1% | $10.89 Million | $14.90 Million | $4.01 Million | ▲ +31.0 pp |
| 2002 | 42.1% | $99.44K | $236.25K | $136.81K | ▲ +295.8 pp |
| 2001 | -253.7% | $-682.96K | $269.19K | $952.15K | ▲ +0.0 pp |
| 2000 | -253.7% | $-682.96K | $269.19K | $952.15K | ▼ -340.3 pp |
| 1998 | 86.6% | $29.01K | $33.51K | $4.50K | — |